Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stage-resolved gene drivers of pancreatic ductal adenocarcinoma progression and therapeutic vulnerabilities.

iScience·2026
Same author

Downregulation of the Transglutaminase 2-NF-κB Inflammatory Axis by a Fusion Protein of Cementoin and Secretory Leukocyte Protease Inhibitor Reduces Corneal Angiogenesis.

International journal of molecular sciences·2026
Same author

Therapeutic Effect of Alpha Lipoic Acid in a Rat Preclinical Model of Preeclampsia: Focus on Maternal Signs, Fetal Growth and Placental Function.

Antioxidants (Basel, Switzerland)·2024
Same author

Secretory Leukocyte Proteinase Inhibitor Protects Acute Kidney Injury Through Immune and Non-Immune Pathways.

Shock (Augusta, Ga.)·2021
Same author

[Non-SARS-CoV-2 biomedical research in times of pandemic and post-pandemic].

Medicina·2020
Same author

Evidencing a Pancreatic Ductal Adenocarcinoma Subpopulation Sensitive to the Proteasome Inhibitor Carfilzomib.

Clinical cancer research : an official journal of the American Association for Cancer Research·2020

Related Experiment Video

Updated: Sep 3, 2025

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

16.1K

Human Endothelial Cell Seeding in Partially Decellularized Kidneys.

Geraldine Haeublein1, Gabriela Lombardi1, Fiorella Caro1

  • 1Universidad de Buenos Aires, Consejo Nacional de Investigaciones Científicas y Técnicas, Centro de Estudios Farmacológicos y Botánicos (CEFYBO), Facultad de Medicina, Buenos Aires, Argentina.

Biomed Research International
|July 25, 2022
PubMed
Summary

Researchers developed a rat-human bioartificial kidney by replacing rat endothelial cells with human ones. This method shows promise for reducing organ graft damage and increasing transplant compatibility.

More Related Videos

Preparation of Decellularized Kidney Scaffolds in Rats
06:09

Preparation of Decellularized Kidney Scaffolds in Rats

Published on: March 18, 2021

4.3K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

7.5K

Related Experiment Videos

Last Updated: Sep 3, 2025

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development
09:43

Epithelial Cell Repopulation and Preparation of Rodent Extracellular Matrix Scaffolds for Renal Tissue Development

Published on: August 10, 2015

16.1K
Preparation of Decellularized Kidney Scaffolds in Rats
06:09

Preparation of Decellularized Kidney Scaffolds in Rats

Published on: March 18, 2021

4.3K
Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
09:00

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology

Published on: March 27, 2018

7.5K

Area of Science:

  • Regenerative Medicine
  • Transplantation Biology
  • Bioengineering

Background:

  • High demand for organ transplants necessitates innovative solutions like xenotransplantation and bioartificial organs.
  • Developing immune-compatible organs is crucial for overcoming transplant limitations.

Purpose of the Study:

  • To describe a method for creating a rat-human bioartificial kidney by partially replacing rat endothelial cells with human endothelial cells.
  • To evaluate different solutions for selective endothelial cell decellularization while preserving parenchymal cells.

Main Methods:

  • Perfusing rat kidneys with 0.1% sodium dodecyl sulfate (SDS), 0.01% SDS, or hyperosmolar sucrose solutions to selectively remove endothelial cells.
  • Recellularizing partially decellularized kidneys with human endothelial cells.
  • Transplanting the bioartificial kidneys into rats and assessing perfusion and urine production.

Main Results:

  • Hyperosmolar solutions and 0.01% SDS achieved partial endothelial decellularization, with hyperosmolar solutions better preserving epithelial cell viability.
  • Recellularized kidneys demonstrated successful attachment of human endothelial cells throughout the vascular bed.
  • Post-transplant, the bioartificial kidneys achieved complete perfusion and produced urine for at least 90 minutes.

Conclusions:

  • Partial endothelial decellularization and recellularization with patient-derived human endothelial cells is a feasible approach for creating bioartificial kidneys.
  • This method holds potential for reducing damage to organ grafts and improving transplant outcomes.